| Literature DB >> 25250309 |
Joo-In Park1, Hae-Rahn Bae2, Chang Gun Kim3, Valentin A Stonik4, Jong-Young Kwak3.
Abstract
Many marine triterpene glycosides have in vitro and in vivo activities with very low toxicity, suggesting that they are suitable agents for the prevention and treatment of different diseases, particularly cancer. However, the molecular mechanisms of action of natural marine compounds in cancer, immune, and other various cells are not fully known. This review focuses on the structural characteristics of marine triterpene glycosides and how these affect their biological activities and molecular mechanisms. In particular, the membranotropic and membranolytic activities of frondoside A and cucumariosides from sea cucumbers and their ability to induce cytotoxicity and apoptosis have been discussed, with a focus on structure-activity relationships. In addition, the structural characteristics and antitumor effects of stichoposide C and stichoposide D have been reviewed along with underlying their molecular mechanisms.Entities:
Keywords: anticancer activity; cucumarioside; frondoside A; membrane transporters; stichoposides; triterpene glycosides
Year: 2014 PMID: 25250309 PMCID: PMC4159031 DOI: 10.3389/fchem.2014.00077
Source DB: PubMed Journal: Front Chem ISSN: 2296-2646 Impact factor: 5.221
Figure 1Structures of STC (1) and STD(2).
Figure 2Structures of frondoside A (3) and cucumariosides (4-6).
Figure 3Structures of aglycone skeleton systems with 9(11) double bond (7), 9β-H-7(8)-unsaturation (8) and 3β, 20S-Dihydroxy-5α-lanostano-18(20)-lactone (9).
Figure 4Structures of plant triterpene glycosides.
Membrane transporters as potential targets of triterpene glycosides from sea cucumbers and plants.
| Pump | Na+-K+-ATPase | Glycyrrhizin Glycyrrhetinic acid | Itoh et al., | ||
| Psolusosides A and B | Gorshkova et al., | ||||
| Ca2+-ATPase in sarcoplasmic reticulum | Cyclopiazonic acid | Uyama et al., | |||
| Astragaloside IV | Xu et al., | ||||
| Multidrug-resistance protein-1 | Saikosaponin-d | Wong et al., | |||
| Ginsenoside Rp1 | Yun et al., | ||||
| Glycyrrhizin | Fu et al., | ||||
| Cucumarioside A2-2 | Menchinskaya et al., | ||||
| Frondoside A | Menchinskaya et al., | ||||
| Na+-Ca2+ exchange | Echinoside-A and –B | Yamasaki et al., | |||
| Channel | Voltage-gated | Voltage-gated Na+ channel | Ginsenoside Rg3 | Lee et al., | |
| Ginsenoside Rb1 | Xu and Huang, | ||||
| Ginsenoside Rg3 | Lee et al., | ||||
| Calcium-activated K+channel | Dehydrosoyasaponin I | McManus et al., | |||
| Ginsenoside Rg3 | Choi et al., | ||||
| Human ether-a-go-go related gene K+ channel | Ginsenoside Rg3 | Choi et al., | |||
| L-type voltage-gated calcium channel | Ginsenoside Rb1 | Lin et al., | |||
| Ligand-gated | Nicotinic acetylcholine receptor | Ginsenoside Rg3 | Lee et al., | ||
| N-methyl-D-aspartate receptor | Ginsenoside Rh2 | Lee et al., | |||
| Ginsenoside Rg3 | Kim et al., | ||||
| GABAA receptor | Ginsenoside Rg3 | Lee et al., | |||
| Ryanodine receptor | Ginsenoside Re | Wang et al., | |||
| Mechanosensitive | Transient receptor potential canonical | 20-O-β-d-Glucopyranosyl-20(S)-protopanaxadiol | Hwang et al., | ||
| Others | Auqaporin-1 | Ginsenoside Rg3 | Pan et al., | ||
| Auqaporin-4 | Astragaloside IV | Li et al., | |||
| Carrier | Glucose transporter (GLUT1, GLUT4) | Ginsenoside Rb1 | Shang et al., |
Sea cucumbers.
Figure 5Structures of 18(20)-lactone in the aglycone with oxygen group.
Figure 6Structures of STA (15) and STE (16).
Figure 7Structure of compound with (17) or without (18) a sulfate group at C-4 of the xylose residue.
Figure 8Structure of cucumarioside H.
Potential molecular mechanisms for anticancer activity of marine triterpene glycosides.
| Frondoside A | Inhibition of proliferation | Increased expression of p21 | 4 μg/mL (AsPC-1 cells) | Li et al., | |
| Induction of apoptosis | Caspase-independent pathway, mitochondrial pathway, increased expression of p53 | 1 μM (HL-60 cells) | Jin et al., | ||
| 2. 5 μM (MDA-MB 231 cells) | |||||
| Decreased expression of Bcl-1 and Mcl-1, increased expression of Bax | 4 μg/mL (AsPC-1 cells) | Al Marzouqui et al., 2011 | |||
| Antimetastatic activity | Inhibition of MMP-9 activation | 1 μM (MDA-MB-231 cells) | Li et al., | ||
| Inhibition of prostaglandin receptors EP4 and EP2 | 0.5 μM (Line 66.1 cells) | Park et al., | |||
| Ma et al., | |||||
| Stichoposide C | Induction of apoptosis | Extrinsic and intrinsic pathway, activation of acid SMase and neutral SMase, ceramide generation | 0.3 μM (HL-60 cells) | Yun et al., | |
| 0.5 μM (K562 cells) | |||||
| Stichoposide D | Induction of apoptosis | Extrinsic and intrinsic pathway, activation of ceramide synthase 6, ceramide generation | 1.5 μM (HL-60 cells) | Park et al., | |
| 1.0 μM (K562 cells) | Yun, | ||||
| Cucumaioside A2-2, A4-2 | Induction of apoptosis | Caspase-dependent pathway | 3 μM (HL-60 cells) | Jin et al., | |
| Echinoside A | Induction of apoptosis | Inhibition of the noncovalent binding of topoisomerase 2α to DNA | 2.4 μM (human cancer cell lines) | Li et al., | |
| Cell cycle arrest | Increased expression of | 2.7 μM (HepG2 cells) | Zhao et al., | ||
| Ds-echinoside A | Antimetastatic activity | Inhibition of NF-κB dependent MMP-9 and VEGF expression | 2.7 μM (HepG2 cells) | Zhao et al., | |
| Philinopside A | Induction of apoptosis | Inhibition of receptor tyrosine kinase autophosphorylation | 1.5−2.4 μM (Sarcoma 180, BEL-7402, MCF-7 cells) | Tong et al., | |
| Philinopside E | Antimetastatic activity | Inhibition of VEGFR2 signaling | ~4 μM | Tian et al., | |
| Inhibition of interaction between KDR and αvβ3 integrin | 2.5 μM | Tian et al., |
Figure 9Structures of EA (20) and DSEA (21).
Figure 10Structures of PA (22) and PE (23).